Triptans for the Management of Migraine

@article{Johnston2012TriptansFT,
  title={Triptans for the Management of Migraine},
  author={Mollie M. Johnston and Alan Mark Rapoport},
  journal={Drugs},
  year={2012},
  volume={70},
  pages={1505-1518}
}
  • Mollie M. Johnston, Alan Mark Rapoport
  • Published 2012
  • Medicine
  • Drugs
  • Migraine is a chronic, recurrent, disabling condition that affects millions of people in the US and worldwide. Proper acute care treatment for migraineurs is essential for a full return of function and productivity. Triptans are serotonin (5-HT)1B/1D receptor agonists that are generally effective, well tolerated and safe. Seven triptans are available worldwide, although not all are available in every country, with multiple routes of administration, giving doctors and patients a wide choice… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 104 CITATIONS, ESTIMATED 58% COVERAGE

    A review of the use of frovatriptan in the treatment of menstrually related migraine

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Pharmacokinetic evaluation of frovatriptan

    VIEW 1 EXCERPT
    CITES BACKGROUND

    FILTER CITATIONS BY YEAR

    2011
    2020

    CITATION STATISTICS

    • 1 Highly Influenced Citations

    • Averaged 8 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 67 REFERENCES